Inhibitors of cyclin-dependent kinases

被引:0
|
作者
Krystof, V
Strnad, M
机构
[1] Palacky Univ, Lab Rustovych Regulatoru, Olomouc 78371, Czech Republic
[2] Akad Ceske Republ, Ustav Expt Bot, Olomouc 78371, Czech Republic
来源
CHEMICKE LISTY | 2001年 / 95卷 / 05期
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Disorders in regulation mechanisms of the cell cycle cause uncontrolled division of cells, which is the nature of neoplastic diseases. Cyclin-dependent kinases (CDK), enzymes of the serine-threonine protein kinase group, belong to main regulators of cell division in all eukaryotic organisms. Their indispensability in regulation of the cell cycle and, in particular, their frequent deregulation in tumours led to active search for chemical inhibitors of CDK. Butyrolactone, flavopiridol, purines of the olomoucine type, paullones, indirubins and others inhibit the CDK, block the cell cycle in the G1/S and G2/M transitions and show interesting anticancer effects. In the article, chemical properties, the mechanism of action and biological activity of the inhibitors are described.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 50 条
  • [1] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    [J]. MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [2] Chemical inhibitors of cyclin-dependent kinases
    Meijer, L
    Kim, SH
    [J]. CELL CYCLE CONTROL, 1997, 283 : 113 - 128
  • [3] Designing inhibitors of cyclin-dependent kinases
    Hardcastle, IR
    Golding, BT
    Griffin, RJ
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 : 325 - 348
  • [4] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    [J]. Molecular Biotechnology, 2001, 19 : 179 - 188
  • [5] Pharmacological inhibitors of cyclin-dependent kinases
    Knockaert, M
    Greengard, P
    Meijer, L
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (09) : 417 - 425
  • [6] Chemical inhibitors of cyclin-dependent kinases
    Coleman, KG
    Lyssikatos, JP
    Yang, BV
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32, 1997, 32 : 171 - 179
  • [7] Chemical inhibitors of cyclin-dependent kinases
    Meijer, L
    [J]. TRENDS IN CELL BIOLOGY, 1996, 6 (10) : 393 - 397
  • [8] Characterization of novel inhibitors of cyclin-dependent kinases
    Kent, LL
    Hull-Campbell, NE
    Lau, T
    Wu, JC
    Thompson, SA
    Nori, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (03) : 768 - 774
  • [9] Identification of inhibitors of cyclin-dependent kinases.
    Veal, JM
    Bramson, N
    Dickerson, S
    Frye, S
    Harris, P
    Hassell, A
    Holmes, B
    Hunter, R
    Kuyper, L
    Lackey, K
    Lovejoy, B
    Luzzio, M
    Montana, V
    Rocque, W
    Shewchuk, L
    Walker, D
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U1021 - U1022
  • [10] Novel arylazopyrazole inhibitors of cyclin-dependent kinases
    Jorda, Radek
    Schuetznerova, Eva
    Cankar, Petr
    Brychtova, Veronika
    Navratilova, Jana
    Krystof, Vladimir
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) : 1975 - 1981